Skip to content

Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women

Effects of Gum Arabic Supplementation on the Components of Metabolic Syndrome Among Post Menopausal Females in Khartoum State 2019

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04978103
Enrollment
100
Registered
2021-07-27
Start date
2019-12-04
Completion date
2022-12-20
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome in Postmenopausal Females

Keywords

Gum Arabic, Inflammatory markers, Metabolic Syndrome

Brief summary

Gum Arabic ingestion has been proved to decrease some of the inflammatory markers in some metabolic diseases that have an inflammatory background. Nevertheless, the mechanism/s by which it does so is uncertain. This study is targeting one of the postulated molecular mechanisms at genetic level that may help to understand how Gum Arabic exerts its effect .The effects of GA on Nuclear Factor Kappa Beta, P38 Mitogen Activated Protein (MAP) Kinase levels, and on the expression of inflammatory cytokines genes are going to be assessed in postmenopausal females with Metabolic Syndrome.

Detailed description

The Metabolic syndrome (MetS) is a collection of several interconnected biochemical, clinical, and metabolic factors that directly increase the risk of atherosclerotic cardiovascular disease and Diabetes Mellitus. Hypertension, Dyslipidemia, insulin resistance, obesity, glucose intolerance, proinflammatory and prothrombotic states are the cornerstone features defining the syndrome. Glycerol, free fatty acids (FFA), tumor necrosis factor alpha (TNFα), interleukin 6 (IL6), interleukin 1(IL-1) and Interferon Gamma (INFγ) are some of the inflammatory substances (cytokines) that are released from different cells (monocytes and adipocytes) in MetS. Gum Arabic is found as a mixture of sodium, calcium and potassium salts of branched polysaccharides. In the colon, GA is fermented by colonic bacteria into short chain fatty acids such as butyrate, which are partially absorbed into blood. Butyrate treatment was found to inhibit expression of cytokine mRNAs in peripheral blood monocytes (PBMC) that are stimulated by bacterial lipopolysaccharide (LPS). In unstimulated (PBMC), a transcription factor (Nuclear Factor kappa β (NF-κB)) controls gene expression of some inflammatory cytokines; Tumor Necrosis Factor Alpha (TNF- α), IL-1 and IL-6. NF-κB was detected mainly in the cytoplasm tightly bound to an Inhibitory protein (IκB). When those cells are stimulated by bacterial lipopolysaccharide (LPS) or by adipokines, NFκB is activated and translocates to the nucleus to start gene expression of the inflammatory cytokines. Moreover; stimulation causes degradation of IκB which releases NFκB and allows its translocation to the nucleus. This nuclear translocation of NFκB was found to be inhibited by butyrate (a byproduct of Gum Arabic fermentation ) providing evidence that butyrate mediated reduction of proinflammatory cytokines was achieved by reducing NFκB activation. Consequently; the postulated mechanisms by which butyrate may regulate gene expression are through inhibition of NFκB activation and IκBα degradation. NFκB and the inflammatory cytokines: Target for therapy in inflammatory diseases, are they? As NFκB is involved in transcriptional regulation of many cytokines genes that contributes to immune and inflammatory responses, it may be a good target for therapy also. At present, treatment of inflammatory diseases depends greatly on aminosalicylates, corticosteroids, and immune-suppressants that decrease cytokines level especially TNF. The anti-inflammatory and immune-modulatory properties of gum Arabic, through butyrate, described previously may offer an interesting alternative therapeutic approach for inflammatory conditions.

Interventions

A dietary supplement (Powdered exudates of Acacia Senegal (Gum Arabic E-414))

Sponsors

University of Khartoum
Lead SponsorOTHER
Ministry of Higher Education and Scientific Research, Republic of Sudan
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Both the investigators and outcome assessors will be given codes of the participants for further analysis

Intervention model description

Postmenopausal females are randomly selected to receive Gum Arabic treatment and intended outcomes will be measured before and after the intervention

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria Females Menopause Metabolic syndrome based on Adult panel II criteria Signed/verbal consent to participate

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Nuclear Factor Kappa Beta concentration in nanogram/dl12 weeksNuclear regulatory protein
P38 Mitogen activated protein kinase in nanogram/dl12 weeksTranscription regulatory protein
Inhibitory Kappa Beta protein in nanogram/dl12 weeksinhibitory protein
Tumor necrosis factor, interferon gamma and interleukin-6 in nanogram/dl12 weeksProinflammatory cytokines
Plasminogen activated protein inhibitor1 in picogram/dl12 weeksProtein Inhibitor
Fasting Insulin in nanogram/dl12 weeksMetabolic hormone
Insulin resistance by HOMA index12 weeksMeasuring cells sensitivity to insulin

Secondary

MeasureTime frameDescription
Fasting Blood Sugar in mg/dl12 weeksBiochemical serological markers
Lipid profile in mg/dl12 weeksSerological markers

Countries

Sudan

Contacts

PRINCIPAL_INVESTIGATORFatima Elhaj, PhD

lecturer in physiology department University of Khartoum

PRINCIPAL_INVESTIGATORShaza Elawad, MSc

lecturer in physiology department University of Khartoum

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026